3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
27
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm Metastasis
4
Leukemia, Biphenotypic, Acute
4
Immunoglobulin Light-chain Amyloidosis
4
Smoldering Multiple Myeloma
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lung Neoplasms
2
Hodgkin Disease
2
Breast Neoplasms
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Plasmacytoma
1
Myelodysplastic Syndromes
1
Meningioma
1
Mastocytosis, Systemic
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
dexamethasone 21-phosphate
×
1 year
×
Clear all
No trials found.